Detalhe da pesquisa
1.
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.
Hepatology
; 79(3): 538-550, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676683
2.
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
Gut
; 73(3): 496-508, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758326
3.
Detailed stratified GWAS analysis for severe COVID-19 in four European populations.
Hum Mol Genet
; 31(23): 3945-3966, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848942
4.
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
J Hepatol
; 80(1): 53-61, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802188
5.
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.
Clin Gastroenterol Hepatol
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782175
6.
Riboflavin-LSD1 axis participates in the in vivo tumor-associated macrophage morphology in human colorectal liver metastases.
Cancer Immunol Immunother
; 73(4): 63, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430255
7.
Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes.
Cardiovasc Diabetol
; 23(1): 4, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172901
8.
Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progression.
Liver Int
; 44(2): 518-531, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010911
9.
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
N Engl J Med
; 383(16): 1522-1534, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558485
10.
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
Gastroenterology
; 163(6): 1630-1642.e3, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150526
11.
Patient-reported quality of care in primary sclerosing cholangitis.
Liver Int
; 43(8): 1654-1662, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312635
12.
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.
Liver Int
; 43(7): 1497-1506, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157905
13.
Age, Origin and Functional Study of the Prevalent LDLR Mutation Causing Familial Hypercholesterolaemia in Gran Canaria.
Int J Mol Sci
; 24(14)2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511081
14.
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.
J Hepatol
; 77(5): 1359-1372, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738508
15.
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
J Hepatol
; 76(5): 1109-1121, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167909
16.
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
Liver Int
; 42(11): 2453-2465, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932095
17.
Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases.
Int J Mol Sci
; 23(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555840
18.
Primary biliary cholangitis.
Lancet
; 396(10266): 1915-1926, 2020 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308474
19.
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
J Viral Hepat
; 28(3): 558-568, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306247
20.
Experimental liver models: From cell culture techniques to microfluidic organs-on-chip.
Liver Int
; 41(8): 1744-1761, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966344